Cargando…
An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms
Sequencing of SARS-CoV-2 genomes is crucial for understanding the genetic epidemiology of the COVID-19 pandemic. It is also critical for understanding the evolution of the virus and also for the rapid development of diagnostic tools. The present protocol is a modification of the Illumina COVIDSeq te...
Autores principales: | Bhoyar, Rahul C., Senthivel, Vigneshwar, Jolly, Bani, Imran, Mohamed, Jain, Abhinav, Divakar, Mohit Kumar, Scaria, Vinod, Sivasubbu, Sridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326003/ https://www.ncbi.nlm.nih.gov/pubmed/34368787 http://dx.doi.org/10.1016/j.xpro.2021.100755 |
Ejemplares similares
-
Evaluation of the reproducibility of amplicon sequencing with Illumina MiSeq platform
por: Wen, Chongqing, et al.
Publicado: (2017) -
Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform
por: Schirmer, Melanie, et al.
Publicado: (2015) -
SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
por: Gupta, Aayush, et al.
Publicado: (2022) -
Illumina MiSeq sequencing analysis of fungal diversity in stored dates
por: Al-Bulushi, Ismail M., et al.
Publicado: (2017) -
1029 genomes of self-declared healthy individuals from India reveal prevalent and clinically relevant cardiac ion channelopathy variants
por: Bajaj, Anjali, et al.
Publicado: (2022)